Opioid Use, Abuse and Prescribing
This continuing education activity is administered by the National Association of Pediatric Nurse Practitioners (NAPNAP) as an Agency providing continuing education credit. Individuals who complete this program and earn a 70% or higher score on the post test will be awarded 2.25 NAPNAP contact hour, of which 1 is pharmacology,1 Psychopharmacology Hour and 2.25 controlled substances.
IMPORTANT: This continuing education activity is offered at a reduced rate to NAPNAP Members. You must be logged in using your NAPNAP Username and Password to be recognized as a Member of NAPNAP. If you are a current member of NAPNAP, and you are being asked to purchase this activity at the Non-Member rate, please contact the NAPNAP National Office at (877) 662-7627 to request assistance prior to entering any payment information.
Participants are forbidden to reproduce, republish, redistribute, or resell this course in any other form. For copyright-related questions, please email your question to: email@example.com
Copyright 2018 © by National Association of Pediatric Nurse Practitioners (NAPNAP)
Pediatric-focused advanced practice registered nurses
- Describe epidemiology and pharmacology of opioid addiction in pediatric and adolescent patients.
- Identify opioid prescribing practices and medication assistive therapies that contribute to a reduction in opioid addiction.
- Discuss federal policies, fiscal and ethical influences on prescribing Schedule II controlled substances.
Kristin Hittle Gigli, PhD, RN, CPNP-AC, CCRN: Pediatric Nurse Practitioner, Pediatric Intensive Care Unit, Children’s Health Children’s Medical Center Dallas, Dallas
Adam Wenner, MSN, RN, CPNP-AC: Pediatric Nurse Practitioner, Pediatric Intensive Care Unit, Children’s Health Children’s Medical Center Dallas, Dallas
Mr. Wenner has no relevant financial relationships to disclose.
Dr. Hittle Gigli has no relevant financial relationships to disclose.
- 2.25 Contact hours